Related Experiment Video
Updated: Feb 14, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Hepatic lipidosis: Clinical review drawn from collective effort
1Veterinary Teaching Hospital, Small Animal Medicine, Colorado State University, 300 West Drake Road, Fort Collins, Colorado, 80523, USA.
Insights
Early diagnosis and treatment of feline hepatic lipidosis (fatty liver) are crucial for a good prognosis. Differentiating between idiopathic and secondary causes impacts treatment and outcomes for cats.
Area of Science:
- Veterinary Medicine
- Small Animal Internal Medicine
- Hepatology
Background:
- Hepatic lipidosis (HL), or fatty liver, is the most common liver dysfunction in cats.
- The prognosis for feline HL is good if recognized and treated early, but grave if delayed.
- Distinguishing idiopathic HL from secondary causes is critical for effective treatment and prognosis.
Purpose of the Study:
- To review the diagnosis and treatment of hepatic lipidosis in cats.
- To highlight the importance of identifying concurrent diseases affecting treatment and outcomes.
- To emphasize the accessibility of diagnostic and therapeutic interventions for practitioners.
Main Methods:
- Review of original studies, expert reviews, and clinical communications.
- Discussion of diagnostic tools, including abdominal ultrasound.
- Emphasis on essential nutritional interventions for anorectic cats.
Main Results:
- Cats, particularly overweight ones that stop eating, are uniquely susceptible to HL.
- Abdominal ultrasound aids in presumptive diagnosis, cytology, and identifying concurrent conditions.
- Necessary equipment for diagnosis and nutritional support is readily available and affordable.
Conclusions:
- Feline hepatic lipidosis requires prompt recognition and management.
- Identifying secondary causes is paramount for successful therapeutic planning.
- Small animal practitioners possess the necessary skills and resources to manage HL effectively.
Abstract:
Practical relevance: Hepatic lipidosis (HL) is the most common form of liver dysfunction in cats. If recognized early and treated appropriately, the prognosis is good; if not, the prognosis is grave. Clinical challenges: Distinguishing HL as idiopathic or secondary is critical since the presence of a concurrent disease affects the therapeutic plan and the prognosis.
Audience:
Despite the unique and severe nature of a cat's response to anorexia and the complexity of the metabolic changes underlying this condition, the clinical acumen and technical ability to effectively diagnose and treat HL are readily available to all small animal practitioners. Patient group: Although many species develop a 'fatty liver', the cat is one of relatively few species that suffer from HL. The classic presentation is that of an overweight cat that stops eating for days to weeks, losing weight in the process. Equipment: Abdominal ultrasound is frequently employed in the diagnostic work-up of an anorectic cat; ultrasonographic findings often support a presumptive diagnosis, provide samples for cytology and, perhaps most importantly, help identify concurrent conditions that must be addressed for therapeutic success. All of the equipment necessary for essential nutritional intervention in an anorectic cat is readily available and easily affordable. Evidence base: The material for this review draws heavily on a relatively large number of original studies, excellent reviews by recognized experts, and informative communication with experienced clinicians, hence the term 'collective effort'.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Data Collection II

